OTC · QLIS
Qualis Innovations, Inc.
Healthcare · Medical - Devices
$0.27
Up+$0.00 (+0.00%)
Updated Aug 17, 2026, 9:27 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 5.45M
- P/E ratio
- -26.07
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 100
- Avg. volume
- 33
Price performance
QLIS price history
1M range · 0 trading sessions · Daily adjusted prices
QLIS does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest QLIS news
The latest Smart Investors Daily articles mentioning QLIS.
Stock researchCompany · Overview
QLIS research
Overview
Company profile and research snapshot.
Company profile
Qualis Innovations, Inc. focuses on the development, production, and distribution of pain management and other central nervous system (CNS) based solutions. Its lead product is SOLACE, a non-invasive medical device to use electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain. The company is headquartered in Chadds Ford, Pennsylvania.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
